Truvian
PrivateLast Round
VC Round
Jul 17, 2024
Total Funding Raised
$176.3M
Company Overview
Truvian is a healthcare technology company that develops an automated benchtop blood testing platform designed to provide lab-accurate diagnostic results in decentralized care settings.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Truvian Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Truvian Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 17, 2024 | ||||
| Debt | Sep 14, 2021 | ||||
| Series C | Feb 24, 2021 | ||||
| Series B | Nov 20, 2019 | ||||
| Series A | Sep 1, 2017 |
Key People
Founding team and executive leadership
Truvian Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series C, VC Round, Series B |
| Wasson Enterprise | Series C |
| Pacific West Bank | Debt |
| Domain Associates | Series B, Series A |
| GreatPoint Ventures | Series C, Series B |
| Medical Excellence Capital | VC Round |
| General Catalyst | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Proprietary blood testing platform is currently under FDA review.
- Jan 13, 2025
Developing a comprehensive benchtop solution for blood testing.
Truvian Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Truvian's valuation, stock price, and market status.